Concordance between clinical trial data use request proposals and corresponding publications: A cross-sectional study

一致性 临床试验 数据共享 医学 计算机科学 临床终点 医学物理学 替代医学 内科学 病理
作者
Enrique Vázquez,Joseph S. Ross,Cary P. Gross,Karla Childers,S. P. Bamford,Jessica Ritchie,Joanne Waldstreicher,Harlan M. Krumholz,Joshua D. Wallach
出处
期刊:Clinical Trials [SAGE]
标识
DOI:10.1177/17407745241304355
摘要

Background/Aims The reuse of clinical trial data available through data-sharing platforms has grown over the past decade. Several prominent clinical data-sharing platforms require researchers to submit formal research proposals before granting data access, providing an opportunity to evaluate how published analyses compare with initially proposed aims. We evaluated the concordance between the included trials, study objectives, endpoints, and statistical methods specified in researchers’ clinical trial data use request proposals to four clinical data-sharing platforms and their corresponding publications. Methods We identified all unique data request proposals with at least one corresponding peer-reviewed publication as of 31 March 2023 on four prominent clinical trial data sharing request platforms (Vivli, ClinicalStudyDataRequest.com, the Yale Open Data Access Project, and Supporting Open Access to Researchers–Bristol Myers Squibb). When data requests had multiple publications, we treated each publication–request pair as a unit. For each pair, the trials requested and analyzed were classified as fully concordant, discordant, or unclear, whereas the study objectives, primary and secondary endpoints, and statistical methods were classified as fully concordant, partially concordant, discordant, or unclear. For Vivli, ClinicalStudyDataRequest.com, and Supporting Open Access to Researchers–Bristol Myers Squibb, endpoints of publication–request pairs were not compared because the data request proposals on these platforms do not consistently report this information. Results Of 117 Vivli publication–request pairs, 76 (65.0%) were fully concordant for the trials requested and analyzed, 61 (52.1%) for study objectives, and 57 (48.7%) for statistical methods; 35 (29.9%) pairs were fully concordant across the 3 characteristics reported by all platforms. Of 106 ClinicalStudyDataRequest.com publication–request pairs, 66 (62.3%) were fully concordant for the trials requested and analyzed, 41 (38.7%) for study objectives, and 35 (33.0%) for statistical methods; 20 (18.9%) pairs were fully concordant across the 3 characteristics. Of 65 Yale Open Data Access Project publication–request pairs, 35 (53.8%) were fully concordant for the trials requested and analyzed, 44 (67.7%) for primary study objectives, and 25 (38.5%) for statistical methods; 15 (23.1%) pairs were fully concordant across the 3 characteristics. In addition, 26 (40.0%) and 2 (3.1%) Yale Open Data Access Project publication–request pairs were concordant for primary and secondary endpoints, respectively, such that only one (1.5%) Yale Open Data Access Project publication–request pair was fully concordant across all five characteristics reported. Of three Supporting Open Access to Researchers–Bristol Myers Squibb publication–request pairs, one (33.3%) was fully concordant for the trials requested and analyzed, two (66.6%) for primary study objectives, and two (66.6%) for statistical methods; one (33.3%) pair was fully concordant across all three characteristics reported by all platforms. Conclusion Across four clinical data sharing platforms, data request proposals were often discordant with their corresponding publications, with only 25% concordant across all three key proposal characteristics reported by each platform. Opportunities exist for investigators to describe any data-sharing request proposal deviations in their publications and for platforms to enhance the reporting of key study characteristic specifications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZHEN发布了新的文献求助10
1秒前
艺玲发布了新的文献求助10
2秒前
dddddddio完成签到 ,获得积分10
2秒前
2秒前
gaos发布了新的文献求助10
2秒前
坦率的可仁完成签到,获得积分10
3秒前
司徒迎曼完成签到,获得积分10
3秒前
烟花应助激情的一斩采纳,获得10
3秒前
天天快乐应助11采纳,获得10
4秒前
36456657应助八九采纳,获得50
4秒前
潦草完成签到,获得积分20
4秒前
华仔应助科研通管家采纳,获得10
4秒前
freesialll完成签到 ,获得积分10
4秒前
深情安青应助科研通管家采纳,获得30
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
大模型应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得20
5秒前
NexusExplorer应助科研通管家采纳,获得10
5秒前
摇摇晃晃完成签到 ,获得积分10
5秒前
5秒前
乐乐应助科研通管家采纳,获得10
5秒前
贪玩手链应助科研通管家采纳,获得20
5秒前
科研通AI5应助科研通管家采纳,获得30
5秒前
CipherSage应助科研通管家采纳,获得10
5秒前
共享精神应助科研通管家采纳,获得10
5秒前
在水一方应助科研通管家采纳,获得10
6秒前
领导范儿应助科研通管家采纳,获得10
6秒前
李健的小迷弟应助liyi采纳,获得10
6秒前
华仔应助科研通管家采纳,获得20
6秒前
研友_VZG7GZ应助科研通管家采纳,获得10
6秒前
赘婿应助科研通管家采纳,获得20
6秒前
FashionBoy应助科研通管家采纳,获得10
6秒前
脑洞疼应助科研通管家采纳,获得10
6秒前
思源应助科研通管家采纳,获得10
6秒前
ding应助科研通管家采纳,获得20
6秒前
6秒前
6秒前
Ava应助科研通管家采纳,获得10
6秒前
华仔应助科研通管家采纳,获得10
7秒前
深情安青应助科研通管家采纳,获得10
7秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527521
求助须知:如何正确求助?哪些是违规求助? 3107606
关于积分的说明 9286171
捐赠科研通 2805329
什么是DOI,文献DOI怎么找? 1539901
邀请新用户注册赠送积分活动 716827
科研通“疑难数据库(出版商)”最低求助积分说明 709740